The elucidation of the domain structure and structure-function relationships of plasma factor XI, the discovery of novel pathways of activation of plasma factor XI and renewed interest in platelet factor XI provide the background for this proposal. Preliminary characterization of partially purified platelet factor XI suggests that its subunit structure likely differs from that of plasma factor XI and that platelet factor XI mRNA lacks exon V of the plasma protein. The objectives of the proposal are to characterize the structure and function of platelet factor XI, to understand the mechanisms of activation and regulation of its enzymatic activity, and to define the functional significance of the interaction between plasma factor XI and platelets including the normal physiologic pathways of factor XI activation and expression and regulation of its enzymatic activity. To accomplish these objectives, the applicant will complete the characterization of factor XI mRNA from platelets ongoing in his laboratory, clone and characterize the factor XI cDNA from megakaryocytes, and purify and characterize factor XI isolated from platelets. The mechanisms and pathways of activation of platelet factor XI and the expression and regulation of its enzymatic activity will be investigated. The hypothesis that platelet factor XI can substitute for plasma factor XI in hemostasis will be tested in studies of patients who lack only plasma factor XI or lack both plasma and platelet factor XI. Finally, the applicant will determine the cellular locus for the activation of factor XI by thrombin, factor XIIa, factor XIa and other coagulation proteases and the role of specific binding of plasma factor XI to platelets in the activation of factor XI and in the expression and regulation of its enzymatic activity.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL056153-02
Application #
2392784
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1996-04-01
Project End
2000-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Temple University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Ahmad, S S; London, F S; Walsh, P N (2003) The assembly of the factor X-activating complex on activated human platelets. J Thromb Haemost 1:48-59
Ahmad, Syed S; Walsh, Peter N (2002) Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface. Biochemistry 41:11269-76
Wilkinson, Frank H; Ahmad, Syed S; Walsh, Peter N (2002) The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex. J Biol Chem 277:5734-41
Wilkinson, Frank H; London, Fredda S; Walsh, Peter N (2002) Residues 88-109 of factor IXa are important for assembly of the factor X activating complex. J Biol Chem 277:5725-33
Sinha, Dipali; Marcinkiewicz, Mariola; Gailani, David et al. (2002) Molecular cloning and biochemical characterization of rabbit factor XI. Biochem J 367:49-56
Walsh, Peter N; Ahmad, Syed S (2002) Proteases in blood clotting. Essays Biochem 38:95-111
Gailani, D; Ho, D; Sun, M F et al. (2001) Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential. Blood 97:3117-22
Sun, M F; Baglia, F A; Ho, D et al. (2001) Defective binding of factor XI-N248 to activated human platelets. Blood 98:125-9
Baglia, F A; Walsh, P N (2000) Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. J Biol Chem 275:20514-9
London, F S; Walsh, P N (2000) Zymogen factor IX potentiates factor IXa-catalyzed factor X activation. Biochemistry 39:9850-8

Showing the most recent 10 out of 24 publications